Literature DB >> 16009030

Management of esophageal symptoms following fundoplication.

Gregory S Sayuk1, Ray E Clouse.   

Abstract

Laparoscopic antireflux surgery has emerged as a widely used and effective management option for the properly selected patient with gastroesophageal reflux disease. Poor symptomatic outcomes occur even in the best of hands, the most common being recurrent or persistent heartburn (or atypical symptoms) and dysphagia. When heartburn predominates, the initial management step is an anatomical and physiologic evaluation to determine whether acid reflux is controlled and if the postoperative neoanatomy is appropriate. If anatomical evaluation indicates surgical failure (eg, slipped or loose fundoplication, recurrent hiatal hernia), earlier re- operation may be warranted. Objective evidence of ongoing acid reflux or a reflux-symptom association despite anatomical integrity indicates reintroduction of antireflux medical therapy. Evidence favoring physiologic and anatomical success should direct treatment toward functional heartburn, including the use of tricyclic antidepressants. Dysphagia in the immediate postoperative setting mandates reassurance, as conservative measures alone often suffice while postoperative changes resolve. With persistent dysphagia, anatomical and physiologic evaluation is again indicated in the search for a mechanical-, motility-, or reflux-related symptom basis. Dilation techniques can prevent the need for re-operation, but persistent dysphagia associated with distorted postoperative anatomy will likely require surgical intervention. Regardless of the indication, re-operation carries substantial morbidity and reduced success rates compared with the initial procedure. These procedures mandate careful patient selection and referral to a center with thorough surgical experience.

Entities:  

Year:  2005        PMID: 16009030     DOI: 10.1007/s11938-005-0022-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  70 in total

Review 1.  Laparoscopic treatment of gastro-oesophageal reflux disease.

Authors:  David I Watson
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-02       Impact factor: 3.043

Review 2.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

Review 3.  Functional chest pain: nociception and visceral hyperalgesia.

Authors:  Premjit S Chahal; Satish S C Rao
Journal:  J Clin Gastroenterol       Date:  2005 May-Jun       Impact factor: 3.062

4.  Achalasia developing years after surgery for reflux disease: case reports, laparoscopic treatment, and review of achalasia syndromes following antireflux surgery.

Authors:  E C Poulin; N E Diamant; P Kortan; P A Seshadri; C M Schlachta; J Mamazza
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

5.  Results of laparoscopic fundoplication where atypical symptoms coexist with oesophageal reflux.

Authors:  R Y Chen; R J Thomas
Journal:  Aust N Z J Surg       Date:  2000-12

Review 6.  Gastroesophageal reflux disease: extraesophageal manifestations and therapy.

Authors:  K R DeVault
Journal:  Semin Gastrointest Dis       Date:  2001-01

7.  Dysphagia after laparoscopic antireflux surgery. The impact of operative technique.

Authors:  J G Hunter; L Swanstrom; J P Waring
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

8.  Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis.

Authors:  M Luostarinen; J Isolauri; J Laitinen; M Koskinen; O Keyriläinen; H Markkula; E Lehtinen; A Uusitalo
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

9.  The cost-effectiveness of treatment strategies for achalasia.

Authors:  J Barry O'Connor; Mendel E Singer; Thomas F Imperiale; Michael F Vaezi; Joel E Richter
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

10.  Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.

Authors:  S J Spechler
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.